a, a N Clinical Trials

A listing of a, a N clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 2490 clinical trials
Morphological Parameters of In-stent RESTenosis Assessed and Identified by OCT

Optical coherence tomography (OCT), a high-resolution endocoronary imaging technique can assist in the understanding of the mechanism of restenosis and guide treatment.

  • 0 views
  • 16 Feb, 2024
  • 1 location
The Positively Quit Trial for Smoking Cessation

The main goal of the present study is to determine if a smoking cessation program designed for people living with certain chronic conditions and delivered via videoconferencing groups works better than a control condition--a program that is not designed to help with smoking but that does have the same number …

  • 0 views
  • 16 Feb, 2024
  • 1 location
Battlefield Acupuncture for Pain in Hidradenitis Suppurativa

The investigators will investigate battlefield acupuncture as a treatment for the pain of hidradenitis suppurativa.

treatment regimen
hidradenitis
  • 0 views
  • 16 Feb, 2024
  • 1 location
Acceptance and Commitment Therapy for Family Caregivers of People With Dementia

The pilot project aims to investigate the feasibility and the preliminary efficacy of a guided online acceptance and commitment therapy (ACT) intervention for distressed family caregivers of people with dementia. A one-group pretest-posttest design (n=15) will be used to investigate the potential effects of the 10 weekly online ACT intervention …

dementia
acceptance and commitment therapy
psychological stress
depression
anxiety
  • 0 views
  • 16 Feb, 2024
  • 1 location
Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel

Participants will receive nilotinib and paclitaxel. The drugs are given in 28-day cycles. Nilotinib is a capsule taken by mouth twice a day. Paclitaxel will be given intravenously by peripheral line or central line once a week for the first 3 weeks of each cycle.

bisphosphonate
adrenal
antineoplastic agents
malignant mixed mullerian tumor
acinar cell carcinoma
  • 0 views
  • 16 Feb, 2024
  • 1 location
Improving Uptake of Genetic Cancer Risk Assessment in African American Women- Video

Black women underutilize GCT compared to White women. This study will conduct a RCT to test the efficacy of a culturally-tailored theory-based video intervention aimed to address key psychosocial factors (emotions, ambivalence) to improve uptake of genetic counseling in Black women at increased risk of HBOC.

ovarian cancer
genetic counseling
  • 0 views
  • 16 Feb, 2024
  • 1 location
Safety and Immunogenicity of CJCV2 With and Without ALFQ

This is a randomized, double-blind, dose-escalating, outpatient trial in a total of approximately 60 subjects, assigned to 3 cohorts (20 subjects per cohort).

Accepts healthy volunteers
  • 0 views
  • 19 Jan, 2024
  • 1 location
Optimising Radiation Therapy in Head and Neck Cancers Using Functional Image-Guided Radiotherapy and Novel Biomarkers

Cohort 1: HPV-associated OPC consisting of 25 participants Cohort 2: HPV-negative OPC consisting of a minimum of 10 patients and a maximum of 53 participants Cohort 3: Base of Skull HNC consisting of 25 participants

chemoradiotherapy
squamous cell carcinoma of head and neck
metastasis
platinum-based chemotherapy
induction chemotherapy
  • 0 views
  • 16 Feb, 2024
  • 1 location
The Effect of Intravenous Ketamine on Non Suicidal Self Injuries.

Non-suicidal self-injuries (NSSI) is a deliberate harm a person causes directly to their body, resulting in structural or functional damage, without suicidal ideation. This behavior is related to unbearable internal stress, thoughts, or mental pain, which NSSI assists in dismantling.

midazolam
hypertension
arrhythmia
psychosis
drug abuse
  • 0 views
  • 16 Feb, 2024
  • 1 location
Global Safety and Efficacy Registration Study of Crinecerfont for Congenital Adrenal Hyperplasia

The study consists of a 6 month randomized, double blind, placebo-controlled period, followed by 1 year of treatment with crinecerfont. Duration of participation is approximately 20 months.

deficiency
congenital adrenal hypoplasia
adrenaline
  • 0 views
  • 16 Feb, 2024
  • 1 location